Article Details

AstraZeneca's Farxiga data shows widespread undiagnosed chronic kidney disease

Retrieved on: 2022-11-07 18:56:54

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's Farxiga data shows widespread undiagnosed chronic kidney disease. View article details on hiswai:

Excerpt

AstraZeneca's (AZ) INSIDE-CKD research has demonstrated that Farxiga could cut 33% of healthcare costs by delaying chronic kidney disease (CKD) ...

Article found on: www.pharmatimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up